Rhythm Pharmaceuticals Inc (RYTM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 41,830 | 33,251 | 29,078 | 25,967 | 24,234 |
| Cost of Goods | 3,786 | 3,828 | 2,947 | 2,807 | 3,233 |
| Gross Profit | 38,044 | 29,423 | 26,131 | 23,160 | 21,001 |
| Operating Expenses | 80,083 | 74,136 | 67,556 | 163,854 | 62,503 |
| Operating Income | -41,253 | -43,885 | -40,478 | -139,887 | -41,269 |
| Interest Expense | 6,003 | 5,242 | 4,603 | 4,755 | 4,379 |
| Other Income | 3,839 | 5,142 | 13,299 | 3,570 | 4,211 |
| Pre-tax Income | -43,417 | -43,985 | -31,782 | -141,072 | -41,437 |
| Income Tax | -89 | -344 | 479 | 300 | 196 |
| Net Income Continuous | -43,328 | -43,641 | -32,261 | -141,372 | -41,633 |
| Net Income | $-43,328 | $-43,641 | $-32,261 | $-141,372 | $-41,633 |
| EPS Basic Total Ops | -0.71 | -0.73 | -0.55 | -2.35 | -0.70 |
| EPS Basic Continuous Ops | -0.68 | -0.71 | -0.53 | -2.35 | -0.70 |
| EPS Diluted Total Ops | -0.71 | -0.73 | -0.55 | -2.35 | -0.70 |
| EPS Diluted Continuous Ops | -0.68 | -0.71 | -0.53 | -2.35 | -0.70 |
| EPS Diluted Before Non-Recurring Items | -0.72 | -0.73 | -0.55 | N/A | N/A |
| EBITDA(a) | $-40,870 | $-43,500 | $-40,088 | $-139,482 | $-40,852 |